ChemMedChem · 2024 · 14 citations · 50 references
MedicineMedicinal ChemistryOncologyDrug DiscoveryMolecular OncologyNeuro-oncologyCancer ImmunotherapyNeuro-oncology Clinical TrialsTargeted Cancer TherapyTargeted TherapyAdministration Of Monoclonal AntibodiesMedicinal Chemistry ApplicationsMonoclonal Antibodies In CancerMulti-target Drug DiscoveryNeuroblastoma BiologyProgenitor CellsSurvival RatesTargeted Therapy Development
Neuroblastoma (NB) is a childhood malignant tumour belonging to a group of embryonic tumours originating from progenitor cells of the sympathoadrenal lineage. The heterogeneity of NB is reflected in the survival rates of those with low and intermediate risk diseases who have survival rates ranging from 85 to 90 %. However, for those identified with high-risk Stage 4 NB, the treatment options are much more limited. For this group, current treatment consists of immunotherapy (monoclonal antibodies) in combination with anti-cancer drugs and has a 40 to 50 % survival rate. The purpose of this review is to summarise NB research from a medicinal chemistry perspective and to highlight advances in targeted drug therapy in the field. The review examines the medicinal chemistry of a number of drugs tested in research, some of which are currently under clinical trial. It concludes by proposing that future medicinal chemistry research into NB should consider other possible target therapies and adopt a multi-target drug approach rather than a one-drug-one-target approach for improved efficacy and less drug-drug interaction for the treatment of NB Stage 4 (NBS4) patients.
50
Mutations affecting segment number and polarity in Drosophila
Christiane Nüsslein‐Volhard, Eric Wieschaus · Nature · 1980 · 4.4K citations
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodème, Kate L. Jeffrey, Uwe Schaefer et al. · Nature · 2010 · 1.6K citations · Full text
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
David M. Berman, Sunil Karhadkar, Anirban Maitra et al. · Nature · 2003 · 1.3K citations
Medicine, Cancer Biology, Oncology +14